Special Feature: Dendritic Cell
Travellers in many guises: The origins and destinations of dendritic cells
Lois L Cavanagh,
Ulrich H Von Andrian,
Lois L Cavanagh
Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorUlrich H Von Andrian
Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorLois L Cavanagh,
Ulrich H Von Andrian,
Lois L Cavanagh
Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorUlrich H Von Andrian
Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
Search for more papers by this authorCBR and Dept of Pathology, HMS, 200 Longwood Ave, Boston 02115, MA, USA. Email: [email protected] and [email protected]
Abstract
The migratory behaviour of dendritic cells (DC) is tightly linked to their differentiation state. Precursor DC constitutively repopulate normal tissues from the bloodstream, and are recruited in elevated numbers to sites of inflammation. Whilst maturing in response to antigenic stimulation, DC acquire the capability to enter lymph nodes via afferent lymphatic vessels, thus facilitating their presentation of antigen to naïve T cells. Peripheral blood monocytes constitute a second DC precursor population, which during an inflammatory response are recruited to the affected site where some differentiate into functional DC. The availability of separate DC precursor populations is thought to be significant for the character, amplification and perpetuation of the resultant immune response. In addition, the balance between steady-state trafficking of incompletely activated DC bearing self-antigens from the periphery, and the migration of fully mature DC from inflammatory sites into lymph nodes might have profound effects upon tolerance induction and activation of T cells, respectively.
References
- 1Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 2002; 99: 351–8.
- 2Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–52.
- 3Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245–87.
- 4Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 2002; 14: 373–9.
- 5Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 1997; 7: 483–92.
- 6Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis. J. Exp. Med. 1996; 183: 1789–96.
- 7Traver D, Akashi K, Manz M et al. Development of CD8 alpha-positive dendritic cells from a common myeloid progenitor. Science 2000; 290: 2152–4.
- 8Merad M, Fong L, Bogenberger J, Engleman EG. Differentiation of myeloid dendritic cells into CD8 alpha-positive dendritic cells in vivo. Blood 2000; 96: 1865–72.
- 9Anjuere F, Martinez del Hoyo G, Martin P, Ardavin C. Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation. J. Leukoc. Biol. 2000; 67: 206–9.
- 10Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255–8.
- 11Robert C, Fuhlbrigge RC, Kieffer JD et al. Interaction of dendritic cells with skin endothelium: a new perspective on immunosurveillance. J. Exp. Med. 1999; 189: 627–36.
- 12Sozzani S, Allavena P, Vecchi A, Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 1999; 66: 1–9.
- 13Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998; 28: 2760–9.
10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 14Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991; 9: 271–96.
- 15von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 2000; 343: 1020–34.
- 16Galibert L, Maliszewski CR, Vandenabeele S. Plasmacytoid monocytes/T cells: a dendritic cell lineage? Semin. Immunol. 2001; 13: 283–9.
- 17Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2002; 2: 151–61.
- 18Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767–811.
- 19Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 1997; 156: 25–37.
- 20Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 1997; 159: 565–73.
- 21Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 1993; 362: 761–3.
- 22Anjuere F, del Hoyo GM, Martin P, Ardavin C. Langerhans cells develop from a lymphoid-committed precursor. Blood 2000; 96: 1633–7.
- 23Izon D, Rudd K, DeMuth W et al. A common pathway for dendritic cell and early B cell development. J. Immunol. 2001; 167: 1387–92.
- 24del Hoyo GM, Martin P, Vargas HH, Ruiz S, Arias CF, Ardavin C. Characterization of a common precursor population for dendritic cells. Nature 2002; 415: 1043–7.
- 25Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000; 1: 199–205.
- 26Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl Acad. Sci. USA 1999; 96: 1036–41.
- 27den Haan JMM, Lehar SM, Bevan MJ. CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000; 192: 1685–95.
- 28Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002; 195: 1289–302.
- 29Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71–81.
- 30Takahara K, Omatsu Y, Yashima Y et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int. Immunol. 2002; 14: 433–44.
- 31Dieu MC, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998; 188: 373–86.
- 32Muller-Hermelink HK, Stein H, Steinmann G, Lennert K. Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am. J. Surg. Pathol. 1983; 7: 849–62.
- 33Facchetti F, de Wolf-Peeters C, Mason DY et al. Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am. J. Pathol. 1988; 133: 15–21.
- 34Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL) -3 and CD40-ligand. J. Exp. Med. 1997; 185: 1101–11.
- 35Olweus J, BitMansour A, Warnke R et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl Acad. Sci. USA 1997; 94: 12 551–6.
- 36O'Doherty U, Peng M, Gezelter S et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487–93.
- 37Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999; 5: 919–23.
- 38Kohrgruber N, Halanek N, Groger M et al. Survival, maturation, and function of CD11c− and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J. Immunol. 1999; 163: 3250–9.
- 39Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183–6.
- 40Siegal FP, Kadowaki N, Shodell M et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835–7.
- 41Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000; 1: 305–10.
- 42Nakano H, Yanagita M, Gunn MD. CD11c (+) B220 (+) Gr-1 (+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001; 194: 1171–8.
- 43Nikolic T, Dingjan GM, Leenen PJ, Hendriks RW. A subfraction of B220 (+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur. J. Immunol. 2002; 32: 686–92.
- 44Hamilton JA. Colony stimulating factors, cytokines and monocyte-macrophages − some controversies. Immunol. Today 1993; 14: 18–24.
- 45Hume DA, Robinson AP, MacPherson GG, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 1983; 158: 1522–36.
- 46Palframan RT, Jung S, Cheng G et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 2001; 194: 1361–74.
- 47Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480–3.
- 48Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999; 11: 753–61.
- 49Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 1995; 57: 827–72.
- 50Stein JV, Rot A, Luo Y et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 2000; 191: 61–76.
- 51Baekkevold ES, Yamanaka T, Palframan RT et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 2001; 193: 1105–12.
- 52Weninger W, Crowley MA, Manjunath N, von Andrian UH. Migratory properties of naive, effector, and memory CD8 (+) T cells. J. Exp. Med. 2001; 194: 953–66.
- 53Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 1998; 187: 205–16.
- 54Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 2000; 12: 336–41.
- 55Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999; 5: 1249–55.
- 56Rescigno M, Granucci F, Ricciardi-Castagnoli P. Molecular events of bacterial-induced maturation of dendritic cells. J. Clin. Immunol. 2000; 20: 161–6.
- 57Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997; 27: 3135–42.
- 58Weiss JM, Sleeman J, Renkl AC et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell. Biol. 1997; 137: 1137–47.
- 59Price AA, Cumberbatch M, Kimber I, Ager A. Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 1997; 186: 1725–35.
- 60Huang Q, Liu D, Majewski P et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001; 294: 870–5.
- 61Sozzani S, Luini W, Borsatti A et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 1997; 159: 1993.
- 62Godiska R, Chantry D, Raport CJ et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 1997; 185: 1595–604.
- 63Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 2001; 167: 1862–6.
- 64Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103–7.
- 65Tomasello E, Desmoulins PO, Chemin K et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 2000; 13: 355–64.
- 66Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 1999; 189: 611–4.
- 67Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068–101.
- 68Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996; 88: 3259–87.
- 69Pendl GG, Robert C, Steinert M et al. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood 2002; 99: 946–56.
- 70Maly P, Thall AD, Petryniak B et al. The α (1,3) fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996; 86: 643–53.
- 71Lowe JB. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int. 1997; 51: 1418–26.
- 72Weninger W, Ulfman LH, Cheng G et al. Specialized contributions by alpha (1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 2000; 12: 665–76.
- 73Homeister JW, Thall AD, Petryniak B et al. The alpha (1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 2001; 15: 115–26.
- 74Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 1999; 19: 91–104.
- 75Fraticelli P, Sironi M, Bianchi G et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 2001; 107: 1173–81.
- 76Sozzani S, Allavena P, D'Amico G et al. Cutting edge: Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 1998; 161: 1083–6.
- 77Liang TW, Chiu HH, Gurney A et al. Vascular endothelial-junctional adhesion molecule (VE-JAM) /JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J. Immunol. 2002; 168: 1618–26.
- 78D'Amico G, Bianchi G, Bernasconi S et al. Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells. Blood 1998; 92: 207–14.
- 79Vanbervliet B, Homey B, Durand I et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 2002; 32: 231–42.
- 80Nakayama T, Fujisawa R, Yamada H et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC) /macrophage inflammatory protein (MIP) -3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int. Immunol. 2001; 13: 95–103.
- 81Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 2000; 164: 6621–32.
- 82Yang D, Chertov O, Bykovskaia SN et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525–8.
- 83Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.
- 84Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J. Invest. Dermatol. 1992; 99: 48S–50S.
- 85Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 1995; 181: 2237–47.
- 86Moodycliffe AM, Kimber I, Norval M. Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology 1994; 81: 79–84.
- 87Randolph GJ. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 2001; 13: 267–74.
- 88Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E- cadherin. Nature 1993; 361: 82–5.
- 89Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 1996; 106: 553–8.
- 90Ratzinger G, Stoitzner P, Ebner S et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 2002; 168: 4361–71.
- 91Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl Acad. Sci. USA. 2000; 97: 12 694–9.
- 92Gunn MD, Kyuwa S, Tam C et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999; 189: 451–60.
- 93Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999; 162: 2472–5.
- 94Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C (4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC) -dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103: 757–68.
- 95Randolph GJ, Beaulieu S, Pope M et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl Acad. Sci. USA 1998; 95: 6924–9.
- 96Weiss JM, Renkl AC, Maier CS et al. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 2001; 194: 1219–29.
- 97Maestroni GJ. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 2000; 165: 6743–7.
- 98Hosoi J, Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159–63.
- 99Ngo VN, Tang HL, Cyster JG. Epstein-Barr-virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 1998; 188: 181–91.
- 100Saeki H, Wu MT, Olasz E, Hwang ST. A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo. Eur. J. Immunol. 2000; 30: 2808–14.
10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 101Wu MT, Hwang ST. CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigen-specific immune responses. J. Immunol. 2002; 168: 5096–102.
- 102Wang B, Zhuang L, Fujisawa H et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 1999; 162: 277–83.
- 103D'Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 2000; 1: 387–91.
- 104Demangel C, Bertolino P, Britton WJ. Autocrine IL-10 impairs dendritic cell (DC) -derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 2002; 32: 994–1002.
- 105Angeli V, Faveeuw C, Roye O et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 2001; 193: 1135–47.
- 106Takayama K, Yokozeki H, Ghoreishi M et al. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. J. Invest. Dermatol. 1999; 113: 541–6.
- 107Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG. Ia-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin. Exp. Allergy. 1989; 19: 597–601.
- 108Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia) − bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 1991; 173: 1345–56.
- 109McWilliam AS, Nelson D, Thomas JA, Holt PG. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. Exp. Med. 1994; 179: 1331–6.
- 110McWilliam AS, Napoli S, Marsh AM et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 1996; 184: 2429–32.
- 111Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 2001; 193: 51–60.
- 112Stumbles PA, Strickland DH, Pimm CL et al. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol. 2001; 167: 228–34.
- 113Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001; 2: 361–7.
- 114Pugh CW, MacPherson GG, Steer HW. Characterization of nonlymphoid cells derived from rat peripheral lymph. J. Exp. Med. 1983; 157: 1758–79.
- 115Huang FP, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 2000; 191: 435–44.
- 116Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 2001; 159: 237–43.
- 117Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J. Immunol. 2000; 165: 4062–8.
- 118Piali L, Weber C, LaRosa G et al. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 1998; 28: 961–72.
10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- 119Zou W, Machelon V, Coulomb-L'Hermin A et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 2001; 7: 1339–46.
- 120Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and downregulated by TNF-α. J. Exp. Med. 1994; 179: 1109–18.
- 121Luscinskas FW, Gimbrone MA Jr. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu. Rev. Med. 1996; 47: 413–21.
- 122Luscinskas FW, Kansas GS, Ding H et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of 1-selectin, β1-integrins, and β2-integrins. J. Cell Biol. 1994; 125: 1417–27.
- 123Luscinskas FW, Ding H, Tan P, Cumming D, Tedder TF, Gerritsen ME. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-alpha-activated vascular endothelium under flow in vitro. J. Immunol. 1996; 157: 326–35.
- 124Gerszten RE, Lim YC, Ding HT et al. Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ. Res. 1998; 82: 871–8.
- 125Lim YC, Snapp K, Kansas GS, Camphausen R, Ding H, Luscinskas FW. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J. Immunol. 1998; 161: 2501–8.
- 126Lu B, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 1998; 187: 601–8.
- 127Gerszten RE, Garcia-Zepeda EA, Lim YC et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999; 398: 718–23.
- 128Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur. J. Immunol. 1999; 29: 700–12.
10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- 129Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83–93.
- 130Cavanagh LL, Saal RJ, Grimmett KL, Thomas R. Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation. Blood 1998; 92: 1598–607.
- 131Barratt-Boyes SM, Henderson RA, Finn OJ. Chimpanzee dendritic cells with potent immunostimulatory function can be propagated from peripheral blood. Immunology 1996; 87: 528–34.
- 132Richters CD, Mayen I, Havenith CE, Beelen RH, Kamperdijk EW. Rat monocyte-derived dendritic cells function and migrate in the same way as isolated tissue dendritic cells. J. Leukoc. Biol. 2002; 71: 582–7.
- 133Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 1996; 184: 695–706.
- 134Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992; 176: 1693–702.
- 135Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol. Rev. 2000; 173: 131–40.
- 136Mohamadzadeh M, Berard F, Essert G et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 2001; 194: 1013–20.
- 137Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 1998; 187: 961–6.
- 138Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic langerhans cells. Nature 1992; 30: 258–61.
- 139Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR, Cruz PD Jr. Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J. Immunol. 1995; 155: 4492–6.
- 140Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse−human rheumatoid arthritis model in vivo. J. Clin. Invest. 1998; 101: 1261–72.
- 141Larregina AT, Morelli AE, Spencer LA et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2001; 2: 1151–8.
- 142Randolph GJ, Furie MB. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J. Exp. Med. 1996; 183: 451–62.
- 143Witmer-Pack MD, Hughes DA, Schuler G et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell. Sci. 1993; 104: 1021–9.
- 144Teitelbaum R, Schubert W, Gunther L et al. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 1999; 10: 641–50.
- 145Piemonti L, Bernasconi S, Luini W et al. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Netw. 1995; 6: 245–52.
- 146Katschke KJ Jr, Rottman JB, Ruth JH et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001; 44: 1022–32.
- 147Muller WA. New mechanisms and pathways for monocyte recruitment. J. Exp. Med. 2001; 194: F47–51.
- 148McEvoy LM, Jutila MA, Tsao PS, Cooke JP, Butcher EC. Anti-CD43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis. Blood 1997; 90: 3587–94.
- 149Forster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23–33.
- 150Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J. Exp. Med. 2001; 194: 1375–84.
- 151Martin P, Ruiz SR, del Hoyo GM et al. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood- borne DC recruitment. Blood 2002; 99: 1282–8.
- 152Fearnley DB, Whyte LF, Carnoutsos SA, Cook AH, Hart DN. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999; 93: 728–36.
- 153Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 1997; 90: 3781–8.
- 154Fong L, Brockstedt D, Benike C, Wu L, Engleman EG. Dendritic cells injected via different routes induce immunity in cancer patients. J. Immunol. 2001; 166: 4254–9.
- 155Maraskovsky E, Brasel K, Teepe M et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996; 184: 1953–62.
- 156Pulendran B, Lingappa J, Kennedy MK et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 1997; 159: 2222–31.
- 157Eggert AA, Schreurs MW, Boerman OC et al. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 1999; 59: 3340–5.
- 158Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 1999; 59: 56–8.
- 159Barratt-Boyes SM, Watkins SC, Finn OJ. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol. 1997; 158: 4543–7.
- 160Berg EL, Yoshino T, Rott LS et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med. 1991; 174: 1461–6.
- 161Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575–85.
- 162Geijtenbeek TB, Krooshoop DJ, Bleijs DA et al. DC-SIGN−ICAM−2 interaction mediates dendritic cell trafficking. Nat. Immunol. 2000; 1: 353–7.
- 163Sato N, Ahuja SK, Quinones M et al. CC chemokine receptor (CCR) 2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1) -inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 2000; 192: 205–18.
- 164Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med. 1999; 190: 1755–68.
- 165Varona R, Villares R, Carramolino L et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 2001; 107: R37–R45.
- 166Cook DN, Prosser DM, Forster R et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000; 12: 495–503.
- 167Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP) -3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J. Exp. Med. 2000; 191: 1381–94.
- 168Schneeberger EE, Vu Q, LeBlanc BW, Doerschuk CM. The accumulation of dendritic cells in the lung is impaired in CD18-/- but not in ICAM-1-/- mutant mice. J. Immunol. 2000; 164: 2472–8.
- 169Xu H, Guan H, Zu G et al. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 2001; 31: 3085–93.
10.1002/1521-4141(2001010)31:10<3085::AID-IMMU3085>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
- 170King PD, Sandberg ET, Selvakumar A, Fang P, Beaudet AL, Dupont B. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 1995; 154: 6080–93.
- 171Inaba K, Pack M, Inaba M, Sakuta H, Isdell F, Steinman RM. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 1997; 186: 665–72.
- 172Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 1994; 153: 256–61.
- 173Kamath AT, Pooley J, O'Keeffe MA et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000; 165: 6762–70.
- 174Holt PG, Schon-Hegrad MA, Oliver J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J. Exp. Med. 1988; 167: 262–74.
- 175Liu LM, MacPherson GG. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 1993; 177: 1299–307.
- 176Hemmi H, Yoshino M, Yamazaki H et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int. Immunol. 2001; 13: 695–704.
- 177Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today 1998; 19: 448–54.
- 178Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000; 191: 411–16.
- 179Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 1998; 188: 2163–73.
- 180Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001; 194: 769–79.
- 181Roncarolo MG, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 2001; 193: F5–9.
- 182Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4 (+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000; 192: 1213–22.
- 183Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001; 193: 233–8.
- 184Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000; 191: 423–34.
Citing Literature
Journal of the Australian and New Zealand Society for Immunology
